The micro(nano)plastics perspective: exploring cancer development and therapy
Xiangying Deng,
No information about this author
Yajun Gui,
No information about this author
Lin Zhao
No information about this author
et al.
Molecular Cancer,
Journal Year:
2025,
Volume and Issue:
24(1)
Published: Jan. 24, 2025
Microplastics,
as
an
emerging
environmental
pollutant,
have
received
widespread
attention
for
their
potential
impact
on
ecosystems
and
human
health.
Microplastics
are
defined
plastic
particles
less
than
5
millimeters
in
diameter
can
be
categorized
primary
secondary
microplastics.
Primary
microplastics
usually
originate
directly
from
industrial
production,
while
formed
by
the
degradation
of
larger
items.
capable
triggering
cytotoxicity
chronic
inflammation,
may
promote
cancer
through
mechanisms
such
pro-inflammatory
responses,
oxidative
stress
endocrine
disruption.
In
addition,
improved
bring
new
perspectives
to
therapy,
studies
drug
carriers
underway,
showing
high
targeting
bioavailability.
Although
current
suggest
association
between
certain
cancers
(e.g.,
lung,
liver,
breast
cancers),
long-term
effects
specific
still
need
studied.
This
review
aimed
at
exploring
carcinogenicity
promising
applications
therapy
provides
important
directions
future
research
emphasizes
multidisciplinary
collaboration
address
this
global
health
challenge.
Language: Английский
Unlocking the Potential of RGD-Conjugated Gold Nanoparticles: A New Frontier in Targeted Cancer Therapy, Imaging, and Metastasis Inhibition
Journal of Materials Chemistry B,
Journal Year:
2024,
Volume and Issue:
12(42), P. 10786 - 10817
Published: Jan. 1, 2024
The
review
highlights
the
potential
of
RGD-conjugated
AuNPs
in
cancer
diagnosis
and
treatment,
including
breast
cancer.
It
emphasizes
need
for
further
research
to
fully
realize
this
technology’s
inspire
future
investigations.
Language: Английский
Near-infrared Photoimmunotherapy: mechanisms, applications, and future perspectives in cancer research
Donald O. Allen,
No information about this author
Madeline JoAnna Szoo,
No information about this author
Tessa D. van Bergen
No information about this author
et al.
Antibody Therapeutics,
Journal Year:
2025,
Volume and Issue:
8(1), P. 68 - 85
Published: Jan. 1, 2025
Abstract
Photoimmunotherapy
(PIT)
involves
the
targeted
delivery
of
a
photosensitizer
through
antibody
conjugation,
which,
upon
binding
to
its
cellular
target
and
activation
by
external
irradiation,
induces
localized
toxicity.
This
approach
addresses
several
limitations
conventional
cancer
therapies,
such
as
chemo-
radiotherapies,
which
result
in
off-target
effects
that
significantly
reduce
patient
quality
life.
Furthermore,
PIT
improves
on
challenges
encountered
with
photodynamic
therapy
(PDT),
nonspecific
localization
photosensitizer,
often
results
unintended
toxicities.
Although
was
first
proposed
early
1980s,
clinical
applications
have
been
constrained
engineering,
conjugation
chemistries,
optical
technologies.
However,
recent
advances
antibody–drug
conjugate
(ADC)
research
emergence
sophisticated
laser
technologies
greatly
benefited
broader
applicability
PIT.
Notably,
near-infrared
photoimmunotherapy
(NIR-PIT)
treatment
for
head
neck
has
approved
Japan
is
currently
phase
III
trials
USA.
A
significant
advantage
over
traditional
ADCs
management
agnostic
nature
PDT,
making
it
more
adaptable
different
tumor
types.
Specifically,
can
act
stem
cells
displaying
resistance
aggressive
phenotypes—a
capability
beyond
scope
alone.
review
provides
an
overview
mechanism
action
NIR-PIT,
highlighting
adaptability
application
therapeutics,
concludes
exploring
potential
advancing
treatments.
Language: Английский
Targeting oxygenases could be a viable anti-metastatic approach in cancer therapy
Pengfei Shi,
No information about this author
Jie Xu,
No information about this author
Hongjuan Cui
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 143375 - 143375
Published: April 1, 2025
Language: Английский
Nanomaterials Based on Hollow Gold Nanospheres for Cancer Therapy
You Li,
No information about this author
Jing Wang,
No information about this author
Ying Li
No information about this author
et al.
Regenerative Biomaterials,
Journal Year:
2024,
Volume and Issue:
11
Published: Jan. 1, 2024
Gold
nanoparticles
have
recently
been
exploited
as
versatile
nanocarriers
in
diagnostic
and
therapeutic
drug
delivery
for
cancer
nanomedicine,
owing
to
their
biocompatibility,
low
biotoxicity,
surface
modifiability
plasma
optical
properties.
A
variety
of
gold
emerged
delivery,
mainly
including
nanorods,
nanocages,
nanostars,
solid
nanospheres
hollow
(HGNs).
Among
these,
HGNs
widely
studied
higher
photothermal
conversion
efficiency,
wider
spectral
absorption
range
stronger
surface-enhanced
Raman
scattering
compared
with
nanospheres.
Therefore,
nowadays,
researchers
prefer
use
other
metal
nanocarriers,
which
can
not
only
play
the
role
controlled-release
drugs
but
also
act
agents
tumor
therapy
diagnosis,
due
properties
modification.
Combined
Au-S
bond
on
HGNs,
targeted
preparation
is
loaded
achieve
precise
delivery.
With
assistance
characteristics
themselves,
efficacy
enhanced.
In
addition,
vital
values
field
bioimaging,
serve
imaging
scattering-guided
preparations
assist
achieving
purpose
diagnosis.
this
review,
we
summarize
synthesis
methods
recent
application
HGNs-based
nanomaterials
diagnosis
therapy.
issues
be
addressed
were
pointed
out
a
bright
prospect
nanomaterials.
Language: Английский